ALLMedicine™ Emerging Infectious Diseases Center

Aug 5th, 2022 - Since the fall 2001 distribution of letters containing Bacillus anthracis spores via the US postal system, increased attention has been paid to the evaluation and management of bioterrorism-related illness. Similarly, the emergence of Severe Acute...

Jul 29th, 2022 - Emerging infectious diseases (EIDs) are defined as diseases that are newly identified, newly introduced, or newly evolved; or diseases that have recently and rapidly changed in incidence or expanded geographic, host, or vector range agents; or pre...

Jul 28th, 2022 - ASCOT is an investigator-initiated, multi-centre, open-label, randomised controlled adaptive platform trial. The study design will allow harmonisation with existing frameworks such as the Sentinel Travellers Research Preparedness Platform for Emer...

Jul 27th, 2022 - The emergence of SARS-CoV-2 and the subsequent COVID-19 pandemic has resulted in significant global impact. However, COVID-19 is just one of several high-impact infectious diseases that emerged from wildlife and are linked to the human relationshi...

Jul 26th, 2022 - Severe Acute Respiratory Syndrome Coronavirus 1 (SARS-CoV-1) emerged 20 years ago presaging a series of subsequent infectious disease epidemics of international concern. The recent emergence of SARS-CoV-2 has underscored the importance of targeted...

May 30th, 2022 - Emerging infectious diseases, especially if caused by bat-borne viruses, significantly affect public health and the global economy. There is an urgent need to understand the mechanism of interspecies transmission, particularly to humans. Viral gen...

Jun 20th, 2020 - This review focused on the use of plant‐based foods for enhancing the immunity of all aged groups against COVID‐19. In humans, coronaviruses are included in the spectrum of viruses that cause the common cold and, recently, severe acute respiratory...

Aug 5th, 2022 - Since the fall 2001 distribution of letters containing Bacillus anthracis spores via the US postal system, increased attention has been paid to the evaluation and management of bioterrorism-related illness. Similarly, the emergence of Severe Acute...

Jul 28th, 2022 - ASCOT is an investigator-initiated, multi-centre, open-label, randomised controlled adaptive platform trial. The study design will allow harmonisation with existing frameworks such as the Sentinel Travellers Research Preparedness Platform for Emer...

Jul 19th, 2022 - The high morbidity and mortality associated with both pandemic and seasonal influenza and the anticipation for future influenza pandemics puts influenza front and center in infectious disease research. Because the natural history and pathogenesis ...

Jul 11th, 2022 - Study Description: This protocol will enroll up to 200 adults per year who are scheduled to be vaccinated against severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) or other emerging pathogens.Participants will provide blood samples prior...

Jul 7th, 2022 - The administration of convalescent plasma is often used for treatment of emerging infectious diseases. This natural history protocol will collect plasma from subjects that were vaccinated to or recovered from an emerging infectious disease of inte...

Aug 2nd, 2022 - In creating a guide about monkeypox for obstetrician-gynecologists, Denise J. Jamieson, MD, MPH, turned to research she relied on during another outbreak of the disease nearly 20 years ago. Dr Denise J. Jamieson Jamieson, the James Robert McCord P...

Jun 8th, 2022 - This transcript has been edited for clarity. Hello. I'm Paul Auwaerter with Medscape Infectious Diseases, speaking from the Johns Hopkins University School of Medicine. Monkeypox joins the legion of occasional emerging infectious diseases that, as...

May 30th, 2022 - Emerging infectious diseases, especially if caused by bat-borne viruses, significantly affect public health and the global economy. There is an urgent need to understand the mechanism of interspecies transmission, particularly to humans. Viral gen...

May 11th, 2022 - The annual cost of Lyme disease in the United States could be nearly $970 million, according to new research. But not all cases of Lyme disease are equally costly. Costs for patients with disseminated Lyme disease were more than twice as high as t...

Apr 25th, 2022 - Testing the DNA of antimicrobial-resistant Plasmodium falciparum in the blood of travelers from malaria-endemic regions may help researchers monitor how drug resistance changes over time, a study from Canada reports. "Malaria remains the deadliest...